202 related articles for article (PubMed ID: 20920193)
21. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
22. Effect of prolonged formalin fixation on the immunohistochemical reactivity of breast markers.
Arber DA
Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):183-6. PubMed ID: 12051639
[TBL] [Abstract][Full Text] [Related]
23. Brief fixation does not affect assessment of hormone receptor expression in invasive breast carcinoma biopsies: paving the road for same-day tissue diagnostics.
Kalkman S; Barentsz MW; Witkamp AJ; van der Wall E; Verkooijen HM; van Diest PJ
Am J Surg Pathol; 2014 Aug; 38(8):1071-8. PubMed ID: 24705310
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical detection of phospho-Akt, phospho-BAD, HER2 and oestrogen receptors alpha and beta in Malaysian breast cancer patients.
Seow HF; Yip WK; Loh HW; Ithnin H; Por P; Rohaizak M
Pathol Oncol Res; 2010 Jun; 16(2):239-48. PubMed ID: 19882362
[TBL] [Abstract][Full Text] [Related]
25. Factors affecting KRAS mutation detection in colorectal cancer tissue.
Yun HG; Lee HJ; Kim BR; Lee JH; Lee JH; Lee MY; Kim DH; Sohn JH; Chae SW; Do IG; Do SI; Kim K
Pathol Res Pract; 2019 May; 215(5):1071-1075. PubMed ID: 30846412
[TBL] [Abstract][Full Text] [Related]
26. Extracardiac rhabdomyomas--presentation of two cases with analysis of AKT/mTOR and ERK1/2 signaling.
Iżycka-Świeszewska E; Wesołowski W; Hermann B
Pol J Pathol; 2015 Jun; 66(2):195-9. PubMed ID: 26247533
[TBL] [Abstract][Full Text] [Related]
27. Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study.
Acs B; Leung SCY; Kidwell KM; Arun I; Augulis R; Badve SS; Bai Y; Bane AL; Bartlett JMS; Bayani J; Bigras G; Blank A; Buikema H; Chang MC; Dietz RL; Dodson A; Fineberg S; Focke CM; Gao D; Gown AM; Gutierrez C; Hartman J; Kos Z; Lænkholm AV; Laurinavicius A; Levenson RM; Mahboubi-Ardakani R; Mastropasqua MG; Nofech-Mozes S; Osborne CK; Penault-Llorca FM; Piper T; Quintayo MA; Rau TT; Reinhard S; Robertson S; Salgado R; Sugie T; van der Vegt B; Viale G; Zabaglo LA; Hayes DF; Dowsett M; Nielsen TO; Rimm DL;
Mod Pathol; 2022 Oct; 35(10):1362-1369. PubMed ID: 35729220
[TBL] [Abstract][Full Text] [Related]
28. Cytological evaluation of biological prognostic markers from primary breast carcinomas.
Makris A; Allred DC; Powles TJ; Dowsett M; Fernando IN; Trott PA; Ashley SE; Ormerod MG; Titley JC; Osborne CK
Breast Cancer Res Treat; 1997 May; 44(1):65-74. PubMed ID: 9164679
[TBL] [Abstract][Full Text] [Related]
29. ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
Filipits M; Rudas M; Singer CF; Fitzal F; Bago-Horvath Z; Greil R; Balic M; Lax SF; Halper S; Hulla W; Wu NC; Liu X; Weidler J; Bates M; Hlauschek D; Gnant M; Dubsky P
ESMO Open; 2021 Aug; 6(4):100228. PubMed ID: 34371382
[TBL] [Abstract][Full Text] [Related]
30. Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.
Huang L; Chen T; Chen C; Chen S; Liu Y; Wu J; Shao Z
World J Surg Oncol; 2013 Nov; 11():307. PubMed ID: 24289519
[TBL] [Abstract][Full Text] [Related]
31. Delay to Formalin Fixation (Cold Ischemia Time) Effect on Breast Cancer Molecules.
Khoury T
Am J Clin Pathol; 2018 Mar; 149(4):275-292. PubMed ID: 29471352
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of phosphoprotein phosphatase 2A predicts worse prognosis in patients with breast cancer: a 15-year follow-up.
Chen PM; Chu PY; Tung SL; Liu CY; Tsai YF; Lin YS; Wang WL; Wang YL; Lien PJ; Chao TC; Tseng LM
Hum Pathol; 2017 Aug; 66():93-100. PubMed ID: 28603063
[TBL] [Abstract][Full Text] [Related]
33. Brief fixation enables same-day breast cancer diagnosis with reliable assessment of hormone receptors, E-cadherin and HER2/Neu.
Halilovic A; Bulte J; Jacobs Y; Braam H; van Cleef P; Schlooz-Vries M; Werner A; Boelens O; Nagtegaal I; de Wilt H; Bult P
J Clin Pathol; 2017 Sep; 70(9):781-786. PubMed ID: 28325747
[TBL] [Abstract][Full Text] [Related]
34. Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index.
Kurozumi S; Matsumoto H; Hayashi Y; Tozuka K; Inoue K; Horiguchi J; Takeyoshi I; Oyama T; Kurosumi M
BMC Cancer; 2017 May; 17(1):354. PubMed ID: 28532429
[TBL] [Abstract][Full Text] [Related]
35. Brief formalin fixation and rapid tissue processing do not affect the sensitivity of ER immunohistochemistry of breast core biopsies.
Sujoy V; Nadji M; Morales AR
Am J Clin Pathol; 2014 Apr; 141(4):522-6. PubMed ID: 24619753
[TBL] [Abstract][Full Text] [Related]
36. A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.
Nitta H; Kelly BD; Padilla M; Wick N; Brunhoeber P; Bai I; Singh S; Ranger-Moore J; Bieniarz C; Tsuda H; Grogan TM
Diagn Pathol; 2012 May; 7():60. PubMed ID: 22647525
[TBL] [Abstract][Full Text] [Related]
37. Immunostaining of estrogen receptor, progesterone receptor, MIB1 antigen, and c-erbB-2 oncoprotein in cytologic specimens: a simplified method with formalin fixation.
Suthipintawong C; Leong AS; Chan KW; Vinyuvat S
Diagn Cytopathol; 1997 Aug; 17(2):127-33. PubMed ID: 9258620
[TBL] [Abstract][Full Text] [Related]
38. The effect of 96-hour formalin fixation on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma.
Yildiz-Aktas IZ; Dabbs DJ; Cooper KL; Chivukula M; McManus K; Bhargava R
Am J Clin Pathol; 2012 May; 137(5):691-8. PubMed ID: 22523206
[TBL] [Abstract][Full Text] [Related]
39. Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens.
Janeva S; Parris TZ; Nasic S; De Lara S; Larsson K; Audisio RA; Olofsson Bagge R; Kovács A
BMC Cancer; 2021 Apr; 21(1):439. PubMed ID: 33879115
[TBL] [Abstract][Full Text] [Related]
40. Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies.
Romero Q; Bendahl PO; Klintman M; Loman N; Ingvar C; Rydén L; Rose C; Grabau D; Borgquist S
BMC Cancer; 2011 Aug; 11():341. PubMed ID: 21819622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
